Results 11 to 20 of about 44,802 (314)

Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype [PDF]

open access: yesJournal of Experimental & Clinical Cancer Research
Background Cancer-associated fibroblasts (CAFs) play a significant role in fueling prostate cancer (PCa) progression by interacting with tumor cells. A previous gene expression analysis revealed that CAFs up-regulate genes coding for voltage-gated cation
Valentina Doldi   +8 more
doaj   +3 more sources

Differential Free Intracellular Calcium Release by Class II Antiarrhythmics in Cancer Cell Lines [PDF]

open access: yesJournal of Pharmacology and Experimental Therapeutics, 2019
Class II antiarrhythmics or β-blockers are antisympathetic nervous system agents that act by blocking β-adrenoceptors. Despite their common clinical use, little is known about the effects of β-blockers on free intracellular calcium (Ca2+i), an important ...
Marta Reyes-Corral   +5 more
semanticscholar   +2 more sources

Modulation of the effects of class Ib antiarrhythmics on cardiac NaV1.5-encoded channels by accessory NaVβ subunits

open access: yesJCI Insight, 2021
Native myocardial voltage-gated sodium (NaV) channels function in macromolecular complexes comprising a pore-forming (α) subunit and multiple accessory proteins.
Wandi Zhu   +6 more
semanticscholar   +3 more sources

Antiarrhythmics in Cardiac Arrest: A Systematic Review and Meta-Analysis.

open access: yesHeart, Lung and Circulation, 2017
Introduction: It is widely accepted that antiarrhythmics play a role in cardiopulmonary resuscitation (CPR) universally, but the absolute benefit of antiarrhythmic use and the drug of choice in advanced life support remains controversial. Aim: To perform
A. Chowdhury   +3 more
semanticscholar   +2 more sources

Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study): Six-Month Follow-Up Study

open access: yesCirculation: Arrhythmia and Electrophysiology, 2011
Background— We previously demonstrated that treatment with antiarrhythmic drugs (AADs) during the first 6 weeks after atrial fibrillation (AF) ablation reduces the incidence of clinically significant atrial arrhythmias and need ...
P. Leong-Sit   +14 more
semanticscholar   +2 more sources

Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants

open access: yesThe Journal of General Physiology, 2017
Local anesthetics, antiarrhythmics, and anticonvulsants include both charged and electroneutral compounds that block voltage-gated sodium channels. Prior studies have revealed a common drug-binding region within the pore, but details about the binding ...
D. Tikhonov, B. Zhorov
semanticscholar   +2 more sources

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation

open access: yesPharmacy in practice, 2012
Atrial fibrillation is a common cardiac arrhythmia, and has been a significant financial burden. Class III antiarrhythmics such as dofetilide, ibutilide, and amiodarone are indicated for rhythm control.
Amy Wang
semanticscholar   +3 more sources

Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

open access: yesJournal of the American College of Cardiology, 1999
OBJECTIVESThis study analyzed the causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.BACKGROUNDBoth implantable cardioverter-defibrillators (ICDs) and antiarrhythmic drugs (AADs) are used as mainstays of treatment for ...
D. Richardson   +16 more
semanticscholar   +3 more sources

Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics

open access: yesPharmacoepidemiology and Drug Safety, 2021
To compare risks of interstitial lung disease (ILD) between patients treated with dronedarone versus other antiarrhythmics.
A. Tave   +9 more
semanticscholar   +1 more source

R-wave double counting secondary to antiarrhythmics and ablation leads to unnecessary shock

open access: yesHeartRhythm Case Reports, 2020
During tachyarrhythmia, class I antiarrhythmics Introduction A 61-year-old man with recurrent ventricular tachycardia (VT) and dual-chamber implantable cardiac defibrillator (ICD) was evaluated following a shock and syncope.
Madhurima Home   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy